Skip to main content

Table 1 Clinical, histopathological and follow-up data for 42 HNSCC patients

From: Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis

Variable

Number

Percent

Site

Larynx

16

38.1

Oropharynx

15

35.7

Hypopharynx

5

11.9

Oral cavity

4

9.5

Otherb

2

4.8

T stagea

1

8

19.0

2

10

23.8

3

10

23.8

4

13

30.1

n/a

1

2.4

N stagea

0

17

40.5

1

6

14.3

2

17

40.5

3

1

2.4

n/a

1

2.4

M stagea

0

40

92.9

1

0

4.8

X

2

2.4

Grade

Well

0

0

Mod

27

64.3

Poor

12

28.6

n/a

3

7.1

 

Surgery

27

64.2

Treatment

RT

13

30.9

 

CRT

2

4.7

Death

Yes

9

21.4

No

33

78.6

Responsec

Complete

29

69.0

Partial

4

9.5

None

7

16.7

n/a

2

4.8

Recurrence

Yes

13

30.9

No

29

69.1

  1. T represents size or direct extent of the tumour, N the degree of lymph node spread and M the presence of metastases
  2. aPathological TNM staging; bTwo patients had primary SCC located in EAC; RT, primary radiotherapy; CRT, primary chemoradiotherapy; cPost-treatment clinical evaluation was undertaken at ~8-12 weeks [complete response is defined as the disappearance of all detectable disease at the primary site on visual inspection and/or imaging; partial response was defined as tumour reduction by >50 %]